A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Hyunji,Jo ^[1] ; Joohyun,Hong ^[1] ; Hongsik,Kim ^[1] ; Hye Ryeon,Kim ^[1] ; Ghee Young,Kwon ^[2] ; Kyung A,Kang ^[3] ; Sung Yoon,Park ^[3] ; Chan Kyo,Kim ^[3] ; Byung Kwan,Park ^[3] ; Jae Hoon,Chung ^[4] ; Wan,Song ^[4] ; Minyong,Kang ^[4] ; Hyun Hwan,Sung ^[4] ; Hwang Gyun,Jeon ^[4] ; Byong Chang,Jeong ^[4] ; Seong Il,Seo ^[4] ; Seong Soo,Jeon ^[4] ; Hyun Moo,Lee ^[4] ; Se Hoon,Park ^[1]

作者单位： Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. ^[1] Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. ^[2] Department of Radiology and Center for Imaging Sciences, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. ^[3] Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. ^[4]

关键词 IMDC poor-risk immune checkpoint inhibitors immunotherapy overall survival renal cell carcinoma sunitinib

DOI 10.3389/fonc.2022.874385

PMID 35574412

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

874385页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除